Pimentel, Franklin Fernandes, Daniel Guimarães Tiezzi, Jurandyr Moreira de Andrade, João Gonçalves, Ana Carolina Ferreira Cardoso, Vivienne Carduz Castilho, Roger Chammas, and Juliano Simões de Toledo. “SYNERGISTIC MECHANISMS OF ACTION: COMPARISON OF ADCC AND SIGNALING PATHWAYS INHIBITION BY TRASTUZUMAB BIOSIMILAR OR ORIGINATOR TRASTUZUMAB IN COMBINATION WITH PERTUZUMAB IN HER2+ BREAST CANCER CELL LINES”. Mastology 31 (October 14, 2021): 9. Accessed September 19, 2024. https://revistamastology.emnuvens.com.br/revista/article/view/981.